Most incidents of hyperkalaemia can be managed with treatment pauses of 72 hours, given its short drug half-life, or the use of oral potassium binders
PlexusDx's Precision Peptide Genetic Test can identify whether your genetic profile predisposes you to higher sensitivity in GLP-1 receptor pathways or metabolic stress responses
If you are nervous about injections, being able to see what you are doing can make the routine feel more controlled
Tirzepatide is a dual agonist, meaning that it mimics both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), providing enhanced metabolic benefits
In doing so, it stimulates the release of insulin by the pancreas
A single class of agent to improve insulin sensitivity together with prevention of IR-associated liver pathology remains to be discovered, although we have shown that a neutrophil-targeting CXCR2 antagonist could offer such a solution [see below, (105)]